 |
Adenovirus-based vector Factor VIII complementary DNA to somatic cells |
|---|---|
| Trade Name | Miniadfviii |
| Orphan Indication | Hemophilia A |
| USA Market Approval | USA |
| USA Designation Date | 1999-12-15 00:00:00 |
| Sponsor | GenStar Therapeutics Corporation;10835 Altman Row, Suite 150;San Diego, California, 92121 |
